Skip to main content
. 2011 Jul;55(7):3125–3132. doi: 10.1128/AAC.00131-11

Fig. 1.

Fig. 1.

First-phase decline in HCV RNA versus baseline plasma IP-10 concentration. A linear fit of first-phase decline in HCV RNA versus baseline IP-10 concentration shows a positive correlation (all patients, r2 = 0.29 and P = 0.0008). First-phase decline was defined as the reduction in HCV RNA observed 24 h after initiation of danoprevir treatment.